The National Medicines Regulatory Authorities (NRA) of ASEAN Member States have developed a new procedure for marketing authorizations: the ASEAN Joint Assessment Procedure. The pilot JA project supported and advised technically by the WHO which started in July 2017 has completed. This is a public announcement for a new JA candidate product.